Metabolic Phenotyping in Personalized and Public Healthcare (notice n° 14577)

détails MARC
000 -LEADER
fixed length control field 02637cam a2200277zu 4500
003 - CONTROL NUMBER IDENTIFIER
control field FRCYB88831976
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250107103856.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250107s2016 fr | o|||||0|0|||eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128003442
035 ## - SYSTEM CONTROL NUMBER
System control number FRCYB88831976
040 ## - CATALOGING SOURCE
Original cataloging agency FR-PaCSA
Language of cataloging en
Transcribing agency
Description conventions rda
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nicholson, Jeremy
245 01 - TITLE STATEMENT
Title Metabolic Phenotyping in Personalized and Public Healthcare
Statement of responsibility, etc. ['Nicholson, Jeremy']
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Name of producer, publisher, distributor, manufacturer Elsevier Science
Date of production, publication, distribution, manufacture, or copyright notice 2016
300 ## - PHYSICAL DESCRIPTION
Extent p.
336 ## - CONTENT TYPE
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type code c
Source rdamdedia
338 ## - CARRIER TYPE
Carrier type code c
Source rdacarrier
520 ## - SUMMARY, ETC.
Summary, etc. Metabolic Phenotyping in Personalized and Public Healthcare provides information on the widespread recognition that a personalized or stratified approach to patient treatment may offer a more efficient and effective healthcare solution than phenotype-led approaches. In order to achieve that objective, a deep personal description is required at the level of the genome, proteome, metabolome, or preferably a combination of these aided by technology. This book, edited and written by the outstanding luminaries of this evolving field, evaluates metabolic profiling and its uses across personalized and population healthcare, while also covering the advent of new technology fields, such as surgical metabonomics. In addition, the text presents specific examples of where this technology has been used clinically and with efficacy, pointing towards a framework and protocol for usage as it hits the clinical mainstream.Translates the conjunction of new surgical tools for intraoperative, real-time, metabolite evaluation and direct analysis of biofluid samples into novel options for augmented clinical decision-makingDiscusses longitudinal sampling from individual patients for stratified medicine Covers high resolution analytical spectroscopy and sophisticated computational modelling for prediction of adverse reactions in critical care scenarios, prognostic evaluation of cancer from biofluidism, and prognostic prediction of metabolism or response of patients to pharmaceutical interventions Encapsulates recent technology options for broader population profiling considerations, in particular, the metabolome-wide association studies (MWAS) that aid the translational researcher in identifying metabolic patterns associated with disease Foreword written by Professor Dame Sally Davies who is the Chief Medical Officer for England
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Nicholson, Jeremy
856 40 - ELECTRONIC LOCATION AND ACCESS
Access method Cyberlibris
Uniform Resource Identifier <a href="https://international.scholarvox.com/netsen/book/88831976">https://international.scholarvox.com/netsen/book/88831976</a>
Electronic format type text/html
Host name

Pas d'exemplaire disponible.

PLUDOC

PLUDOC est la plateforme unique et centralisée de gestion des bibliothèques physiques et numériques de Guinée administré par le CEDUST. Elle est la plus grande base de données de ressources documentaires pour les Étudiants, Enseignants chercheurs et Chercheurs de Guinée.

Adresse

627 919 101/664 919 101

25 boulevard du commerce
Kaloum, Conakry, Guinée

Réseaux sociaux

Powered by Netsen Group @ 2025